Home > Boards > US Listed > Biotechs > Neuronetics Inc. (STIM)

$STIM / #Neuronetics Inc +60% Potential Upside

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TFMG Member Profile
Member Level 
Followed By 58
Posts 2,228
Boards Moderated 4
Alias Born 04/28/19
160x600 placeholder
Neuronetics Unveils New Clinical Data at Clinical TMS Society 2021 Annual Meeting GlobeNewswire Inc. - 6/9/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2021 6:27:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2021 7:16:22 PM
Neuronetics to Present at The JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/3/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:30:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:29:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:28:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:28:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:28:16 PM
Neuronetics Names Todd Cushman as Vice President, Business Development GlobeNewswire Inc. - 6/1/2021 8:00:00 AM
Neuronetics to Present at the William Blair 41st Annual Growth Stock Conference GlobeNewswire Inc. - 5/20/2021 8:00:00 AM
Neuronetics marks 100K NeuroStar treatments at Southern California TMS Center Seeking Alpha - 5/17/2021 9:08:45 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/4/2021 4:35:49 PM
ARNC, BLRX, BLDP and MAXR among midday movers Seeking Alpha - 5/4/2021 12:40:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/4/2021 7:38:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/4/2021 7:31:30 AM
Neuronetics EPS beats by $0.01, beats on revenue Seeking Alpha - 5/4/2021 7:23:28 AM
Neuronetics Reports First Quarter 2021 Financial and Operating Results GlobeNewswire Inc. - 5/4/2021 7:00:00 AM
Neuronetics Employee Patient Advocates Honor Mental Health Awareness Month by Sharing Personal Depression Experiences GlobeNewswire Inc. - 5/3/2021 8:00:00 AM
Neuronetics To Present Clinical Data at The American Psychiatric Association 2021 Annual Meeting GlobeNewswire Inc. - 4/29/2021 8:00:00 AM
Neuronetics to Report First Quarter 2021 Financial and Operating Results and Host Conference Call GlobeNewswire Inc. - 4/20/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/14/2021 5:20:41 PM
Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors GlobeNewswire Inc. - 4/14/2021 5:15:14 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/14/2021 4:10:47 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/14/2021 4:07:33 PM
TFMG Member Level  Wednesday, 08/12/20 08:39:45 PM
Re: None
Post # of 19 
$STIM | #Neuronetics Inc +60% Potential Upside


Neuronetics , Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. The firm offers NeuroStar TMS , a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.
Average Analysts Recommendation: BUY
Average Target Price: $5.75






Official InvestorsHub (IHUB) Profile for #TFMG | #theFinancialMarketingGroup:

#BullishCharts - https://investorshub.advfn.com/BullishChartscom-38003/

#TopMarketGainers - https://investorshub.advfn.com/Chart-Analysis-TopMarketGainerscom-36847/
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences